Amgen close to Onyx takeover, deal possible within week-sources

NEW YORK (Reuters) – Onyx Pharmaceuticals Inc is close to selling itself to larger rival Amgen Inc after the cancer drugmaker’s high stock price discouraged other companies from making a counter offer, according to three people familiar with the matter.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.